BioCentury
ARTICLE | Company News

Cobra Bio, University of Cambridge, University of London, U.K. Department of Trade and Industry infectious news

June 11, 2007 7:00 AM UTC

CBF and the universities received a £1.1 million ($2.2 million) grant from the department to evaluate and develop CBF's ORT-VAC live bacterial oral vaccine technology. The funds will be used to suppor...